South Africa’s medical experts will be meeting to discuss the implications of the US’s decision to pause the administering of the Johnson and Johnson (J&J) vaccine following reported cases of rare blood clots. In a joint statement, the US Food and Drug Agency and the Centres for Disease Control and Prevention recommended pausing the J&J vaccine because of an “abundance of caution”. Six patients developed a rare blood clot disorder after receiving the vaccine.

Published on


Add Smile FM on Google

Latest articles

Busy city pedestrian routes turn into an open-air gallery

   One of Cape Town's busiest pedestrian routes turns into an open-air gallery. Every weekday, approximately 30,000 pedestrians walk several surveyed routes in Cape Town,...

Things every South African needs to know about having a will

 There are many things South Africans need to know about having a will. So says Mariska Redelinghuys, the Employee Benefits and Fiduciary Specialist at...

OPINION: Annual two-pot withdrawals could cost an employee R1 million at retirement

Annual two-pot withdrawals could cost an employee R1 million at retirement. R399 600 now, or R1.01 million more later. That's the choice facing employees...